The acquired immunodeficiency syndrome (AIDS) was first described in 1981 and its causal agent, the human immunodeficiency virus (HIV), was identified in 1983. The rapid spread of infection by the virus has made a major impact on many fields of medical practice, now with over 100 000 reported cases of AIDS world wide. ' In the United Kingdom, since the first AIDS cases were described in 1983 There are two major reports of aseptic, seronegative arthritis occurring in association with HIV infection, predominantly in male homosexuals. In Winchester's series of 13 patients with Reiter's syndrome,3 and in Forster's series from London of nine patients with inflammatory joint disease, joint involvement was generally oligoarticular and asymmetrical involving principally the joints of the lower limbs. In both series joint symptoms were generally severe. In addition, other features associated with arthritis were noted in both series, including urethritis, conjunctivitis, uveitis, stomatitis, and keratoderma blenorrhagica. The relation of arthritis to infection in these patients is of considerable interest. Infection could be important in two ways: either HIV infection may render individuals more susceptible to arthritis induced by other micro-organisms or it may cause synovitis directly. In Winchester's series possible precipitating infections were documented in three patients: enteric infection with Shigella flexneri in two, and in one septic arthritis and septicaemia due to Campylobacter fetus preceded the arthritis. The London group examined their patients particularly for evidence of chlamydial infection. In no case was C trachomatis isolated from the genital tract, and in only one patient was evidence of IgG antibody response to C trachomatis demonstrated. This patient had a past history of Reiter's syndrome and therefore this IgG response may not represent recent infection. Also, patients with HIV infection tend to develop poor antibody responses to new antigens despite the presence of hypergammaglobulinaemia so that serological tests are more difficult to interpret. Recently, evidence of deposition of chlamydial antigen in synovium of patients with sexually acquired reactive arthritis has been demonstrated5; using the same technique chlamydial antigen could not be demonstrated in synovial biopsy specimens from two patients with HIV infection. Interestingly, the London group have recently reported two patients with arthritis, a history of acute diarrhoea, and serological evidence of recent yersinia infection (one Y pseudotuberculosis, one Y enterocolitica).6 Apart from organisms classically associated with reactive arthritis it is also important to consider a pathogenetic role for other organisms, the host response to which may be altered by the presence of HIV infection. Other infections which have been noted to occur at the time of onset of arthritis include oral candidiasis, herpes zoster, and perianal herpes simplex. 4 The possibility that HIV may be directly involved in the development of synovitis is supported by several observations. A retrovirus related to HIV has been isolated from the synovium of goats with chronic arthritis (caprine arthritis-encephalitis syndrome),7 and inoculation of this virus into specific pathogen free goats' kids produces arthritic lesions similar to those of the spontaneous disease. HIV has been isolated from synovial fluid of patients with arthritis,4 8 9 though this may merely reflect widespread dissemination of the virus. A recent study from Zimbabwe showed an association between HIV and seronegative arthritis in a group of 13 patients.10 Arthritis in this series was not associated with HLA-B27, a feature consistent with a virus induced arthropathy.
Many Joint symptoms may be severe in HIV positive patients and this poses problems of management. In many cases non-steroidal anti-inflammatory drugs do not control symptoms,3 4 yet treatment with immunosuppressive agents, such as methotrexate and azathioprine given inadvertently before patients were known to be HIV positive, has been associated with clinical deterioration and the appearance of Pneumocystis carinii pneumonia and Kaposi's sarcoma. Clearly, immunosuppressive therapy should be avoided in these patients and even the role of intra-articular steroid injection is open to question. It will be important to evaluate the effect of other drugs, such as sulphasalazine and antiviral agents, in the control of rheumatic symptoms.
The development of inflammatory joint disease in HIV positive individuals poses several practical problems. Firstly, the possibility of HIV infection should be considered in patients presenting with seronegative arthritis, especially if they are from high risk groups. The London experience is that up to half of HIV positive patients presenting with arthritis may not be known to have HIV infection previously.6 It may therefore be necessary to counsel patients appropriately and arrange for HIV antibody testing. Secondly, for the sake of doctors and laboratory staff great care must be taken over clinical procedures and handling of pathological samples including synovial fluid from these patients. 
